Dr. Monica Wattana is a provider in the MD Anderson Emergency Center and an Assistant Professor in the Department of Emergency Medicine. She is board-certified in Emergency Medicine and joined MD Anderson in 2012. She is a member of American Board of Emergency Medicine since 2014. Degree-Granting Education 2008- University of California School of Medicine, Irvine, CA, USA, MD, Medicine Postgraduate Training 2012-2014 Clinical Fellowship, Emergency Medicine, Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 2008-2012 Clinical Residency, Emergency Medicine, University of California at Los Angeles, Los Angeles, CA

Emergency Medicine

Professor Robert Bor is a chartered clinical, counselling and health psychologist registered with the Health and Care Professions Council. He is also a Fellow of the British Psychological Society and a UKCP registered family and couples therapist having specialised in systemic therapy at the Tavistock Clinic, London. Rob is an honorary civilian consultant to the Royal Air Force. He has published more than 30 books and 200 academic papers and chapters in books. He is a Liveryman of the Guild of Air Pilots and Air Navigators and also holds the Freedom of the City of London. Professor Bor is a Churchill Fellow. Qualifications DPhil CPsychol CSci FBPsS UKCP Reg FRAeS

Infectious diseases

Born in Madrid (Spain) in November, 3, 1967. He studied Medicine obtaining his tittle in 1991 in University Complutense of Madrid. Pediatrician from 1997 on. In last 25 years he has made research about different topics mainly depending on pediatric infectious disease and General Pediatrics. He has published over 30 papers in specialized Journals, most of them in Spanish review and 7 of them in international Journals as Pediatric Infectious Disease Journal or Journal of Inmunology. 20 of those writing as a first author. He´s also author of chapters in different spanis books in a number of 7. He has made different speechs as well in Congress, Meetings and other scientific pediatric events, usually in Spain Nowadays he does pediatric attendance at Hospital Infantil Universitario Niño Jesus at pediatric room, emergency pediatric department and teaching fellow in pediatrics. He also works as assistant professor of Pediatrics Department in University Autonoma of Madrid

Pediatric infectious disease and General Pediatrics

Dr. Robert W. Buckingham joined PHHS after having previously been appointed as the Jack W. Thompson, M.D. Distinguished Visiting Professor at the University of Michigan-Flint in 2013-14. A Yale graduate, Dr. Buckingham was appointed inaugural Executive Director/Dean of the School of Public Health with the University of Saskatchewan, in 2009. He has authored more than 12 books and many scientific referred papers, with the most recent being a textbook entitled, “A Primer on International Health” published by Allyn & Bacon, and five books on hospice care, including, “Care of the Dying Child” published by the Continuum Publishing Company, which was translated in seven languages.

Dr. Buckingham, helped pioneer the development of the first Hospice in the U.S. and is considered one of the “Founding Fathers” of hospice in North America. He was the first Director of Research of hospice in Connecticut in 1974, and subsequently founded another 81 hospice programs worldwide, including a hospice for children afflicted with HIV/AIDS in Thailand. Dr. Buckingham has developed new collaborative research and scholarly exchanged programs with Mahidol University in Thailand, Hawassa University in Ethiopia, as well as the Nelson Mandela Institute of Science and Technology in Arusha, Tanzania and locally, with the Heart and Stroke Foundation of Saskatchewan.

evin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

Biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Head of UNESCO Chair sexual health & Human rights, and Public health professor in Paris Diderot University

Sexual health, Human Rights, HIV, STIs, Brief Sexual Communication, globale approach in sexual education, training of sexuality educator

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Infectious Diseases

João R. Mesquita (D.V.M., M.Sc.; Ph.D.) is a Professor at the Polytechnic Institute of Viseu where he teaches topics within Infectious Diseases for more than 12 years. On the past decade he has focused on Virology, where he has published over 50 papers in Scopus indexed Journals. He has won several scientific prizes from different societies and conferences, where he has presented numerous oral and poster presentations. His research interests are focused on animal and human virology, mainly on zoonotic viruses, with special interest on surveillance tools and epidemiology.

animal and human virology, zoonotic viruses, special interest on surveillance tools and epidemiology

Dr Evans is a clinical laboratory director with a PhD in medical microbiology and immunology. He currently serves as a senior laboratory and informatics consultant to the Association of Public Health Laboratories (APHL) which is the parent organization of all state and local public health laboratories in the United States. During this time, he has been involved with APHL/CDC projects in Haiti, Kenya, Indonesia, Namibia, Uganda and Zimbabwe. As a microbiology and infectious disease consultant for the American Society for Microbiology, he has participated in CDC antimicrobial resistance surveillance and other programs in Ethiopia, Kenya and Bangladesh. Dr Evans serves on the New York State Board for Clinical Laboratory Technology and was the first chairman of the state board established in 2006. He is the recipient of APHL's Thomas E Maxson Education, Training and Workforce Development Award for significant contributions to Public Health Laboratory Practice. In 2013, Dr Evans concluded 6 years of public health laboratory service as an Associate Director at the New York City Public Health Laboratory.Key responsibilities included Director of Technical Affairs, Acting Manager of the Microbiology Section & LIMS Project Leader. Previously, Dr Evans spent 14 years in the private sector as a clinical laboratory director at Quest Diagnostics and SmithKline Beecham Clinical Laboratories. Prior to his work in the diagnostic laboratory, he was in academia including positions at Temple University and the University of Zimbabwe Faculty of Medicine. He is also a New York State licensed medical technologist.

Antimicrobial resistance, microbial pathogenesis, laboratory assessment tools, LIMS implementation and improving laboratory quality indicators

Dr Sanjib Bhakta is a Reader (Associate Professor) in Molecular Microbiology and Biochemistry, Strategic Dean (International and Partnership) and Programme Director of MRes Global Infectious Diseases at the Institute of Structural and Molecular Biology, Birkbeck, University of London and UCL .His continued research interest in infectious bacterial diseases (funded by Wellcome Trust, Medical Research Council, UK and EU) is focussed on developing novel therapeutics as well as repurposing existing drugs to tackle antibiotic resistance and persistence in tuberculosis (TB), a global health emergency. He has published more than 100 original research articles for a number of internationally acclaimed journals including J. Exp. Med., JBC, Tuberculosis, Biochem. J., J. Antimicrob. Chemotherapy, FEBS J, Molecular Microbiology, British Medical Journal, PLOS, Journal of Medicinal Chemistry and Nature Sci Report.

infectious bacterial diseases,developing novel therapeutics as well as repurposing existing drugs to tackle antibiotic resistance and persistence in tuberculosis (TB),

Dr. Joshi is director of center for surgical infections at Drexel University; and a professor of Drexel’s Biomedical Engineering, Science and Health Systems, Nyheim Plasma Institute, Dermatology, and Surgery. At Drexel University, his laboratory is renowned for studying novel nonthermal plasma-based technologies in infection control. He has a special interest in emerging bacterial infections, biofilms, novel infection control strategies. Since 1987, Dr. Joshi has taught undergraduate, postgraduate and doctoral students, and trained doctoral, postdoctoral, and resident fellows in medical research. He has been mentoring graduates and medical students, who now have successful careers in medicine, academia and the pharmaceutical industry. Since 2004, he has been a member of international mentoring program and minority mentoring program of American Society of Microbiology (ASM), and Infectious Disease Society of America (IDSA). He is a physician-researcher-teacher and eligible member of American Board of Medical Microbiology. In 2016, Dr. Joshi is elected as a Fellow of Infectious Disease Society of America.

Research Interest: Emerging bacterial infections, host-pathogen interactions and immune responses, hospital-acquired infections and molecular epidemiology, wound infection and wound healing, antimicrobial drug resistance, novel infection control strategies, carbapenem-resistant Acinetobacter baumannii, botulism, MRSA & bacterial biofilms, biodefense bacterial vaccines, nonthermal plasma applications in infection control.

Dr.V. O. Fadipe holds a PhD degree in Chemistry (Organic/Natural Product) from University of Zululand, South Africa. He is presently Principal Research Fellow /Assistant Director with Federal Ministry of Science and Technology, Abuja, Nigeria. He has several research publications in chemistry of natural product for the treatment of TB. His research interest is in the bio-prospecting for drug lead candidates from natural products (plant and animal) for management & treatment and repositioning of existing drugs for infectious diseases particularly TB and TB/HIV. He is a member of several learned society in chemistry.

Research interest is in the bio-prospecting for drug lead candidates from natural products (plant and animal) for management & treatment and repositioning of existing drugs for infectious diseases particularly TB and TB/HIV

Prof Wilson Parawira is the Executive Dean, Faculty of Science, Bindura University of Science Education, Zimbabwe. He has over 20 years of experience teaching in various universities. His main teaching area is Microbiology and Biotechnology. He has held the following positions during his career: Lecturer, Senior Lecturer, and Associate Professor and currently is a full Professor in Microbiology and Biotechnology. Currently, Professor Parawira is the Executive Dean of Faculty of Science at Bindura University of Science Education since August 2012. Professor Wilson Parawira holds a BSc Honours degree in Biological Sciences MSc in Biotechnology from University of Zimbabwe. He obtained his PhD degree in Environmental Biotechnology from Lund University, Sweden in 2004. He did his first postdoctoral research fellowship in 2008 at Lund University in Sweden in Anaerobic Digestion and his second postdoctoral research fellowship in in Fermentation Process Development in Departments of Process Engineering and Microbiology, University of Stellenbosch, South Africa in 2009. During his academic career, he has written 36 scientific articles and three book chapters and supervised several MSc and PhD students and serves as an editor of three scientific journals. His research interests are in environmental biotechnology; biofuels; food microbiology; and science, engineering, technology and innovation policies and their effectiveness. Prof Parawira is an External Examiner at the Department of Molecular Biology and Biotechnology at University of Dar Es Salaam, Tanzania and Department of Biological Sciences at University of Namibia, Department of Environmental Science, University of South Africa, and Department of Applied Biology and Biotechnology, Midlands State University, Zimbabwe. Prof Parawira has examined many PhD and MPhil theses from several universities.

Environmental biotechnology; biofuels; food microbiology; and science, engineering, technology and innovation policies and their effectiveness.

Dr. Ajadi Isaac is a medical doctor from Nigeria with eight years of work experience in clinical medicine both at teaching hospitals and private facilities. He had his medical training at Ladoke Akintola University Teaching Hospital where he later served before joining the medical team at Onabisi Onabanjo Teaching Hospital both located in the South-Western part of the country. Due to his strong passion for medicine, he founded Divine Treasure private hospital which has now birthed many other branches across the country. As an accolade to his academic achievements, Dr. Ajadi recently bagged a master's degree in Health Science with a focus on Preeclampsia and HIV pathogenesis at the University of KwaZulu-Natal in South Africa. He intends to continue his research in HIV pathogenesis at PhD levels in the same university. Dr. Ajadi is also a prolific writer, a motivational speaker and a proprietor of Treasure International College.

HIV pathogenesis ,medicine

Dr. Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as MSU director of Institute of International Health. He is currently Professor of Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the journal of HIV and AIDS Review. He is currently on editorial board member for AIDS Patient Care and STDs. Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

His research interests are Clinical Pharmacology of HIV/AIDS & TB, human gut microbiome, antibiotic resistance, prevention and control of infectious diseases, neglected tropical diseases, community health, global health, socio-ethical determinants of health, and community-based public health interventions. In collaboration with his Brazilian colleagues, he conducts research in the eastern Brazilian Amazon population on incidence and prevalence of HIV, TB, Hepatitis C, HPV, and antimicrobial resistance.

Dr. Qingzhong Kong graduated with B.S. and M.S degrees in Biochemistry at Nanjing University, China, in 1987 and 1990, respectively. In 1996, he completed a Ph.D. in Molecular Virology at the University of Massachusetts. From 1996 to 2000, he was a Research Associate in Molecular Immunology at Yale University, after which he joined the Department of Pathology at Case Western Reserve University as an assistant professor. Dr. Kong is currently a tenured Associate Professor of Pathology at Case Western Reserve University, where he also holds secondary appointments at the Department of Neurology and the National Center for Regenerative Medicine.

His laboratory focuses on prion diseases, functions of cellular prion protein, and muscle stem cells, including four main research areas: (1) etiology of sporadic Creutzfeldt-Jacob disease (CJD) in humans; (2) public health risks of animal prions (Chronic Wasting Disease of elk and deer, atypical Bovine Spongiform Encephalopathy of cattle, and Transmissible Mink Encephalopathy) and animal modeling of various human prion diseases (especially CJD); (3) the roles of the normal cellular prion protein in the biology and pathology of skeletal muscles and brain; and (4) muscle stem cells. His lab has created dozens of transgenic mouse lines for the above research areas, some of which are inducible by doxycycline or conditional when used with Cre recombinase expressing mice.

Yiping Li, Ph.D., Professor of Molecular Virology, Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University (SYSU), Guangzhou, China. Dr. Yiping Li received Ph.D. degree in Biochemistry and Molecular Biology from China Agricultural University, Beijing, China. From 2003 to 2004 and 2006 to 2007, Dr. Li worked as a visiting scholar, project researcher, and postdoctoral researcher in the National Veterinary Institute, Technical University of Denmark (previous Royal Danish Veterinary Institute). In 2005, Dr. Li pursued hepatitis C virus (HCV) research in the Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada. To continue HCV research, in February 2008 Dr. Li joined the Copenhagen Hepatitis C Program (CO-HEP), Hvidovre Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. After trainings as a postdoc and senior investigator, Dr. Li took a professor position in Zhongshan School of Medicine, SYSU in January 2014

Dr. Yiping Li’s research interests are in the infection and immunity of HCV. To HCV research, Dr. Li has made important contributions, which have included the discoveries on the host RNA insertion-mediated viral resistance to antiviral effect of miR-122 antagonism, the development of novel full-length infectious culture systems for HCV genotypes 1a, 2a and 2b, as well as chimeric culture systems for HCV genotypes 3a, 4a, 5a, and 6a. Dr. Li’s works have led to publications on well-known journals, such as PNAS, Gastroenterology, Hepatology, PLoS Pathogens, Virology. In addition, Dr. Li also worked on animal viruses and Campylobacter. Dr. Li’s research activities have produced 25 publications, 3 U.S. patent applications and 21 conference abstracts; these have included 12 first author publications (served also as corresponding author in 3 publications) and 5 oral presentations out of 13 first author abstracts in outstanding conferences.

María José Figueras is a researcher at the Department of Basic Medical Sciences of the URV, and a state ambassador for the American Society of Microbiology (ASM, American Society for Microbiology). The network of ambassadors of the ASM aims to promote knowledge of microbiology through state representatives throughout the world. Dr. Figueras now has the mission of strengthening the relationship between the ASM and the scientific community in Spain, as well as collaborating globally with the more than 70 ambassadors of the entity. The ASM is one of the oldest and largest scientific societies in the world. The entity currently has more than 40,000 members, almost half of whom reside outside the United States. Among its objectives is the improvement of health, the environment and economic well-being, through the development and communication of microbiological sciences. María José Figueras graduated (1979) and PhD (1986) in Biology from the University of Barcelona and specialized in electronic microscopy at the University of Groningen (Netherlands). He has developed his professional career in the Biology and Microbiology Unit of the Faculty of Medicine and Health Sciences of the Rovira i Virgili University, where he has been Professor of Microbiology since 2000. In 2012, he received URV recognition for quality of its research with an impact superior to the world average in the area of Microbiology.

Water related and waterborne infections, Taxonomy and epidemiology of the emerging pathogens Aeromonas and Arcobacter and Taxonomy and epidemiology of the Legionella.

He graduated from the National Autonomous University of Mexico (UNAM, 1985-1989), Assistant Professor of the Department of Veterinary Surgery at UNAM 1989-l993. He is diploma in Surgery and Orthopedics in small species. He is founding President of the Association of Veteran Doctors Specialists in Small Species of Celaya, External Advisor of IDEXX Laboratories, and world leader in diagnostic equipment since 2003. He is currently Director of cirugiaveterinaria.mx National and Latin American Speaker in the area of diagnosis and Surgery. He is author of video books of continuous training in veterinary surgery.

Prevalence of zoonotic diseases in animals.

Dr.R Harihara Prakash is the Principal and Professor at K M Patel Institute of Physiotherapy,Karamsad. He has 18 years of professional experience in clinical as well as academics. He is a Doctorate in Physical Therapy from National University of Medical Sciences, Spain. He was awarded with Rashtriya Vidhya Saraswathi Puraskar Award for his excellent contribution in academics. He was former Dean, Faculty of Physiotherapy, Baba Farid University of Health Sciences, Punjab. He is in the Editorial Board and peer reviewer for some international journals. He is also in the panel of NAAC. He has obtained various skills by certification in the field of neurology, osteopathy, manual therapy from various countries. He has published and presented research papers in various national and international conferences. He is an eminent speaker and an academician.

Physiotherapy in preventive and promotive health.

Dr. Pankaja Raghav is Post graduate (MD) from Aurangabad University and joined D Y Patil Medical College, Pune (1998-2010), she was appointed as Head of the Community medicine Department at ACS Medical College, Chennai (2010 -2012) and now she is working as Professor & Head of the Department of Community medicine & Family medicine at AIIMS, Jodhpur since 2012. She also did postgraduate diploma in hospital & health management (PGDHHM) in 2006 & FAIMER Fellowship in 2013.She has 17 years of post MD teaching & research experience. She has carried out a number of research studies in the fields of nutrition, communicable diseases, non-communicable chronic diseases, child behavior, adolescents, accidents, substance abuse & medical education. She has published over 30 research articles in national and international journals of repute and has been on editorial board for the journals.Awarded the “Most Popular and the Best Teacher” of Padm. D. Y. Patil Medical University in 2008 and University Gold Medal for PGDHHM , IGNOU ,New Delhi; award was given by Vice President of India. She is the life member of many professional bodies to name a few Founder Member and Vice President of Indian Public Health Association, Rajasthan Chapter Member of ‘Consultation Group’ of experts and stakeholders to understand epidemiology of re-emerging H1N1 and other communicable diseases. She is a Member of National Academy of Sciences (India).

Non-communicable diseases, Nutrition and Medical education.

Dr. Maria Lourdes Gozali has completed her Medical degree at the University of Santo Tomas, Philippines. She finished her pediatric residency and fellowship in infectious diseases in Makati Medical Center in the Philippines. She served as a former chairman of the Department of Pediatrics of Asian Hospital and Medical Center and was also chief of the section of the Pediatric Infectious Diseases in Makati Medical Center and Asian Hopsital and Medical Center. She is an active consultant in both hospitals, as well as in St. Luke’s Medical Center Global City.

Pediatric Infectious Diseases

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Zoonotic Diseases

Dr. Fekadu Abebe is a scientist at the Faculty of Medicine, University of Oslo, Norway. He obtained his PhD in immunology from the Department of Immunology and Transfusion Medicine, Ulleval University Hopsital, University of Oslo. After completion of his PhD training, he was employed as a postdoctoral fellow at the Faculty of Medicine, University of Oslo. He received his BSC (Biology) and MSc (Parasitology) from the Faculty of Natural Sciences, Addis Ababa University, Ethiopia. He has been a researcher and lecturer at Aklilu Lemma Institute of Pathobiology, Addis Ababa University for many years. Dr. Abebe`s work include plant molluscicide, epidemiology and immunology of schistosomiasis, with special emphasis on specific antibody responses and puberty-related hormones on Schistosoma mansoni worm load. Dr. Abebe`s group was the first to show the influence of dehydroepiandrosterone- sulphate (DHEAS) on Schistosoma mansoni worm load in humans. Currently, Dr. Abebe is engaged in tuberculosis research, including tuberculosis epidemiology, immunology and molecular genetics. He is leading major projects that deal with molecular genetics, epidemiology, immunodiagnosis, protective immune markers during Mycobacterium tuberculosis in human population. Dr. Abebe`s publications include cytokine profile during latent and progress tuberculosis; the Beijing genotype of Mycobacterium tuberculosis and the protective efficacy of BCG; serodiagnosis of tuberculosis; and the protective role antibody responses during Mycobacterium tuberculosis infection. Dr. Abebe`s main research interest is immunology of tuberculosis, including cell-mediated and antibody responses; immunodiagnosis, and vaccine immunology

Infectious diseases epidemiology and control, Infection and immunity, including vaccines and vaccinations, and immunodiagnosis

Dr. Linana Monica Deac working at Public Health Institute, Cluj-Napoca, Regional Public Health Center, Ro National Public Health Institute, Babes – Bolyai University – 2004 to present. 1993-2000, Head of the Transylvania Epidemiology Department ( for 12 regions) 1997 – 2004 Head of several Academic and National researches and studies for epidemiology and microbiological etiology of specific infectious diseases 2005- present : Staph and Strepto - coccical infect. , Nosocomial infections , Hand washing as preventive activity for Infect Dis., Foodborn infection, Infectious diarrhea in children, Giardioza infect in population from Transylvania, Immunization studies in Romania; Coordination of general and particular actions for prevention of Infect Dis in Ro. 2 Regional awards, for prevention activity in elderly people’s pathology ( 2010 and 2012).

Epidemiology and Public Health

Huseyin Kayadibi was born and raised in Istanbul, Turkey. He received a Degree in Medicine from the GATA School of Medicine (Turkey) in 2000. He is an Associate Professor in Medical Biochemistry at Hitit University School of Medicine, where he is the head of Medical Biochemistry. He worked at Pasarow Mass Spectrometry Laboratory, University of California Los Angeles in 2012 as a visiting scholar. He has been a co-investigator on NIH and other international projects about metabolomic, proteomic and lipidomic analysis. He is the member of EFLM Working Group Test Evaluation and IFCC Working Group Cerebrospinal Fluid Proteins. He has published more than 70 papers in peer reviewed journals. His research interests are non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Refat Sadeq, Prof. and Head of Medical Microbiology and Immunology Department, Faculty of Medicine, Port said University, Egypt. He has been on microbiology field over 40 years. He has started and graduated in Zagazig Faculty of Medicine for M.Sc. and Ph.D. Then started to research articles reaching more than 80 articles, many of which have been published in international scientific journals, and he has reviewed over 150 articles on different journal sites. He is a Featured Author, for books in Medical Microbiology and Immunology for both medical students and nurses. Work from 2008-2011 as Head of Microbiology Department, Faculty of Medicine- Zagazig University. Also work as member of Egyptian scientific committee for graduation of Professor and assistant Professor in Microbiology in Egypt and some Arabic countries. He signed as Board editor of EC Microbiology Journal and Journal of Human Virology and Retrovirology. Since Oct 2014 he pointed as a Head of Microbiology and Immunology department, Faculty of Medicine, Port said University. He is very goal-oriented, assisted in building many units in his department but the favorite one was that of Virology and Molecular biology. He loves how to help junior doctors in his department to solve their scientific problems. His advice to new contributors is to take your time to get to know all the tools and to invest your energy and be sure that success will happened.

Virology and Molecular biology.

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Eugenie Bergogne-Berezin is a Professor of Clinical Microbiology at University Diderot, Paris. She has studied MD in Medicine and PhD in Sciences in the early 1970s. She is a Chief of Department of Clinical Microbiology and research group, University Bichat Claude-Bernard and developed research on Acinetobacter spp., (nosocomial pathogen, pathogenicity, resistance), pharmacology of antibiotics, tissue distribution (lungs, brain, bronchi), research on intestinal ecology, jejunal flora and bacterial adhesion. She is an Adviser to pharmaceutical companies, expert in pharmacology-toxicology for the Ministry of Health, expert for international journals. She has developed a journal Antibiotics, (Elsevier). She has published 6 medical books, many chapters in international infectious diseases books, 200 articles in scientific journals.

Antibiotics

Dr. Theresa I. Dale, Ph.D., CCN, NP Founder & Dean, California College of Natural Medicine, Ventura, CA. President & CEO, The Wellness Center for Research & Education, Inc. Author * Inventor * Researcher * Biological Medical Consultant Dr. Dale’s interest in non-invasive therapies became her passion when she was diagnosed with a uterine tumor at 22 years of age. After healing herself of the tumor by herself in six months using only natural medicine, she decided to make natural medicine her career. She completed her Naturopathic Studies in Europe. In 1992 Dr. Dale founded The Wellness Center for Research and Education, Inc. The California College of Natural Medicine (501C3) was then founded to train health providers in advanced Biological Medicine. A Winning Combination! Dr. Dale is the “Pioneer of Hormone Rejuvenation” with over 20,000 case studies using her advanced formulas NuFem & EndoPure for Men and Women and her “Five Element Salivary Test” panel with her custom Wellness ProgramMoreover, Dr. Dale’s organic herbal and clean nutritional formulas have been proven successful in clinical testing. Furthermore, Advanced Homeopathic research lead to her formulation of the first Fibonacci Sequenced Homeopathic product line. She offers lectures and workshops to medical professionals and speaks at various conferences. Dr. Dale has authored two books “Revitalize Your Hormones; Dr. Dale’s 7 Steps to a Happier, Healthier and Sexier You” and "Transform Your Emotional DNA, Understanding the Blueprint of Your Life”.

non-invasive therapies

K C Santosh worked as a research fellow at the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). He worked as a postdoctoral research scientist at the LORIA research centre, Universite de Lorraine in direct collaboration with industrial partner ITESOFT, France, for 2 years. He also worked as a research scientist at the INRIA Nancy Grand Est research centre for 3 years, until 2011. K C Santosh has demonstrated expertise in pattern recognition, image processing, computer vision and machine learning with various applications in handwriting recognition, graphics recognition, document information content exploitation, medical image analysis and biometrics. He published more than 60 research articles, including a book section in encyclopedia of electrical and electronics engineering.

Electrical and electronics engineering

Lalit Garg has received his PhD degree from the University of Ulster, UK in 2010. He has received his first degree in Electronics & Communication Engineering from the Barkatullah University, India in 1999 and Postgraduate degree in Information Technology from ABV-IIITM, Gwalior, India in 2001. He is currently a Senior Lecturer in Computer Information Systems at the University of Malta, Malta. He was a Researcher at the Nanyang Technological University, Singapore and at the University of Ulster, UK. His research interests include missing data handling, machine learning, data mining and their applications especially in the healthcare domain. He has published more than 60 technical papers in refereed journals and conferences.

Electronics and communication engineering

John J.S. Cadwell received his degree in pharmacology from the University of Miami in 1981. He spent additional time studying at the University of Nottingham and the National Institute of Medical Research at Mill Hill, U.K.. In 2000 he founded FiberCell Systems Inc., a company specializing in the research and supply of hollow fiber bioreactors. He has over 10 publications in the field and three patents relating to hollow fiber systems and is considered a world expert in the field.

Hollow fiber bioreactors

Associate Director of Clinical Proteomics Core Dept. of Pathology and Laboratory Medicine University of California Health System USA

Disease Biomarkers for Studies on Tuberculosis (TB)

Dr. Maximilian Lackner earned his PhD in 2003 and his habilitation in 2009 from Vienna University of Technology. He has held several senior leadership positions in the polymer industry in Austria and China. Dr. Lackner has founded 5 companies, amongst them one for antimicrobial polymers and one in the area of bioplastics, Lackner Ventures & Consulting GmbH. This company collaborates with JinHui Zhaolong, one of the largest PBAT manufacturers. The research interests of Dr. Lackner include PHA and PBAT. Lackner Ventures & Consulting GmbH runs a research project to produce PHB from CO2 and sunlight using cyanobacteria. Dr. Lackner has authored more than 100 scientific articles. He teaches materials science at the University of Applied Sciences FH Technikum Wien.

Dr. Maximilian Lackner's research interests include PHA, PBAT and polymers

Jintao Li, female, Professor, Director and Principle Investigator, Institute of Tropical Medicine, Third Military Medical University(TMMU). She got her master degree in molecular biology from Biotechnology Centre, Southwest University in 1996 and then became a faculty in Genetics Department, TMMU and got her Ph.D degree in Immunology Institute, PLA, TMMU in 2000 and became associate professor and then professor later since then till to 2013. From 2011-2012, she worked in Canada as a visiting scientist for one year. Now she has published more than 100 academic papers such as Science Translational Medicine, J.I, E.J.I, etc. and got 5 items of awards. Awards and group menberships 2010 Chongqing Natural Science Prize “Antigen immune response regulation” 2009 First class of Chinese medical award “Antigen protein antigenic properties and Engineering Research” 2005 Chongqing natural science prize “Relationship with the immune response to a protein antigen characteristic” 2003 Excellent graduate doctor in TMMU 1993~1996 University first grade Scholarship 1989~1993 University second grade Scholarship

Tropical Pathogens and Epidemiology, Immunology, Biotechnology & Molecular Biology

Dr. Mubarak Ahmad Khan is Chief Scientific Officer (CSO) and Director General, Atomic Energy Research Establishment, Bangladesh Atomic Energy Commission. He did his Ph.D. in Radiation and Polymer Chemistry. He is working in several promising areas of Radiation Chemistry and Processing Technology, natural fiber reinforced polymer composites, nanotechnology, material science, biomedical science, applied science etc. Also experience in fiber reinforced polymer composite materials for various applications such as parts and body of auto car, panelized constriction materials, and bodies of electric appliances. Totally biodegradable composite materials based on natural fibers and degradable (both and synthetic) thermoplastic and resin for biomedical purposes. His focus is to use radiation-processing technology for biomedical purposes, renewable energy, Dye sensitized solar cell, modification of natural fibers; stimuli-responsive materials, hydrogel, scaffold form natural polymers. He has conducted research works in many countries including America, Germany, Japan and etc. He has worked in Germany (Technical University of Berlin, Fraunhofer Institute of Applied Polymer Research) as DAAD and Alexander von Humboldt (AvH) fellow, in Japan as MIF Fellow, as visiting scientist, in Australia (University of New South Wells) as IAEA fellow. Trained in Nuclear and Radiation Chemistry through various training course organized by IAEA. He is a part time Professor of Dhaka University, and visiting professor and examiner of various universities of Bangladesh. He is author/co-author of about 600 publications including 16 book chapters and a patent. He has served as project director/co-project director of different national and international scientific project on polymer science. Reviewers of different International Journals on Polymer and Composite Science as well Radiation supervised more than 300 M.Sc. 8 M. Phil and 13 PhD. Students. He is part time/visiting Professor of different universities of home and abroad. He has invented advanced wound dressing material from cow bone, liquid bio-fertilizer from textile effluent, natural plant growth promoter from prawn shell etc. He is also the inventor of Jutin (Jute Reinforced Polymer Corrugated Sheet) the outstanding housing material from jute plastic composite and food preservative using oligo chitosan (alternative to the formalin), He is awarded several national and international awards including Bangladesh Academy of Science Gold Medal awards 2010 for his remarkable contribution to scientific community. He is also awarded and honored by various social and academic institutes in home and abroad, He is also selected as Fellow of International Union of Pure and Applied Chemistry (IUPAC). His name was published in How’s Who in World in 1998. He visited more than 22 countries for participating different seminars, workshops, symposiums, conferences as invited speaker or speaker.

Chief Scientific Officer

Dr. Mandy Hill has acquired a wealth of academic experience in the design, development, and implementation of behavioral research within a clinical setting. Trained as a clinical researcher, Dr. Hill has a documented history of advancing a prevention-based public health agenda within a clinical environment. Her academic portfolio to date has been based on creating a niche of merging public health and emergency medicine. She has published 22 peer reviewed manuscripts, 10 of which she first authored, in diverse areas addressing health disparities among disadvantaged minority populations, coupled with 25 abstracts, 20 presentations and extramural funding support from the Center for Disease Control and Prevention and the National Institutes of Health through the American Psychological Association and Centers for AIDS Research, as well as industry sponsored research. These tangible outcomes attest to her scientific contributions to date. Her primary research focus is HIV/AIDS, STIs, and STDs. In summary, here expertise includes the design, implementation, and analysis of pilot and exploratory studies, randomized clinical trial development and implementation, and integrating public health-based prevention research into routine clinical visits in the emergency department.

HIV/AIDS, STIs, and STDs

Marc H V Van Regenmortel is currently an Emeritus Research Director at the CNRS (French National Research Center) in the School of Biotechnology of the University of Strasbourg, France. He was for 22 years Director of the Immunochemistry Laboratory at the CNRS Molecular Biology Institute in Strasbourg and previously was a professor at several universities in South Africa and France. He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He supervised the research work of 30 PhD students and has published 400 research and review papers as well as 17 books in the fields of Virology and Immunochemistry. In 2009 he co-edited with Brian Mahy of the CDC in Atlanta, the third edition of the Encyclopedia of Virology in 5 volumes published by Elsevier. He is currently Editor-in-Chief of Archives of Virology, Journal of Molecular Recognition and Journal of AIDS & Clinical Research; An Associate Editor of Advances in Virus Research, Frontiers in Immunotherapies and Vaccines, Journal of Immunological Methods, ISRN Immunology and Bionomina.

General virology, Immunochemistry of viruses, viral diagnostics, synthetic peptide vaccines, HIV vaccines, SPR biosensors, viral taxonomy, philosophy of science

Dr. Kimberly A. Parker is an Associate Professor at Texas Womans University in Denton, TX. She has earned a PhD from the University of Georgias College of Public Health, a MPH from the Arnold School of Public Health at the University of South Carolina, and is a Master Certified Health Education Specialist. Dr. Parker conducts qualitative and mixed-methods research on women and minority health issues and currently serves as the Principle Investigator for several research projects. Her primary studies are Be-PrEPared, a curriclum development project to assess the implementation of a multi-strategies intervention to increase knowledge and awareness about PrEP among cis- and trans-women of color, Lend Us Your Voice Project, a qualitative study which examines the lived experience of HIV positive African American women in the South, and the HIV risk assessment study which examines multiple variables associated with contracting HIV, social vulnerabilities, and HIV risk perceptions among African American women. She has also spearheaded several public health curriculum design and evaluation projects related to HIV prevention and womens health issues. Dr. Parker has written several manuscripts on HIV/AIDS, the intersection of race and gender, and minority health issues, and has served as a guest columnist for the Dallas Morning News and The Body. Her research interest includes social sexual factors that influence HIV transmission and health disparities among vulnerable populations.

.

Dr Stef Stienstra is a Strategic and creative development manager in biomedical science, with a parallel career as a reserve commander of the Royal Dutch Navy. For the Dutch Armed Forces he has a responsibility in the counter measures in CBNRe threats and consequence management both in a military and in a civilian (terrorism) context. In his civil career he works internationally as consultant or as scientific supervisory board member for several medical and biotech companies. At this moment for MT-Derm in Berlin (D) developing a novel intradermal vaccination technology, IQ Therapeutics in Groningen (NL) developing therapeutic antibodies against anthrax and orthopox viruses, Hemacon in Düsseldorf (D) developing a field donor blood separation and blood transfusion unit, Infection Control in Eemnes (NL) developing a bio-disinfection system for bioterrorism consequence management and IB Consulting in The Hague (NL) for biodefense projects. He has finished his studies Medicine and Biochemistry in The Netherlands and has extensive practical experience in cell biology, immuno-haematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

CBRN defense, (therapeutic) vaccines, trauma healthcare, blood transfusion, sailing

Timms is Professor of Microbiology and Director of Research at QUT’s Institute of Health and Biomedical Innovation in Brisbane Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. Timms has published over 170 refereed journal papers and is editor of the journal, Pathogens and Disease.

He leads a well established research team of 10 people. His research group is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas.

Kevin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

covert chemical, biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Enric Pedrol is from Fundació Sant Hospital Infectious Diseases, Internal Medicine (General Medicine), Spain

Infectious Disease, Medicine, HIV, Infection, AIDS, Hepatitis C, Liver, Hepatitis Viruses

Ishwar Gilada: A medical doctor, specialized in Skin & STDs with special training in HIV management, Managing Director and Consultant in HIV/AIDS at Unison Medicare& Research Centre-India’s first private sector comprehensive HIV Care clinic; President of AIDS Society of India (a professional organization of physicians in HIV care); Secretary General of Peoples Health Org. (India). He was Secretary General of ASI from 2005-2011 and the Jt. Sec. of National AIDS Committee, Govt of India (1995-97). He was the first to raise alarm against AIDS in 1985, is known for bringing India on AIDS control map, had started India’s first AIDS Clinic-1986 and has expertise in HIV care in resource-poor settings. He had trained several doctors, nurses and social workers; he was Editor-Publisher of AIDS ASIA from 1993 to 2008. He initiated, managed, supervised, evaluated over 40 HIV/AIDS projects in India, addressed over 3700 public meetings and training programs in India and abroad, has 235 scientific papers at conferences, written chapters in books on AIDS/STDs. He was consultant for American Foundation for AIDS Research (AmFAR), World Vision, USAID; has more than 65 awards to his credit including the "Outstanding Young Person of the World" –Glasgow in 1995 and Annemarie Madison Award-Germany in 1999 in Munich, Germany where he was termed as ‘the Indian Machinegun against AIDS’.

Specialized in Skin & STDs with special training in HIV management

Dr. Guirakhoo joined GeoVax as Senior Vice President R&D in October 2015. Dr. Guirakhoo was named one of the ‘50 Most Influential People in Vaccines’ in Vaccine Nation’s 2014 list. His previous assignment was Chief Technology Officer at Vaxess Technologies, a Cambridge, MA, based biotechnology company researching thermostabilization of vaccines and biologics using silk fibroin protein. Prior to this, he served as Chief Scientific Officer at Hookipa Biotech in Vienna, Austria, developing vaccines against Cytomegalovirus and cancers based on a novel replication deficient viral vector platform. Prior to that, Dr. Guirakhoo held the position of Executive Director of External R&D at Sanofi Pasteur from 2007-20012. Before joining Sanofi Pasteur in 2007, Dr. Guirakhoo was Head of Virology Research at Acambis for 15 years. During this time, he co-invented the ChimeriVax TM -technology platform in association with St. Louis University. This platform utilizes the YF 17D vaccine virus as a vector to develop chimeric live viruses. The ChimeriVaxTM vector platform was successfully used in the development of innovative vaccines such as: a) a single dose vaccine against Japanese encephalitis (IMOJEV™), marketed in Asian countries by Sanofi, b) a single dose veterinary vaccine for the prevention of West Nile encephalitis (PREVNILE™), marketed by Merck Animal Health, and c) DENGVAXIA®, the world’s first dengue vaccine approved in Mexico and Brazil in December 2015 and marketed by Sanofi. This tetravalent vaccine represents a historic milestone for half of the world population who lives at risk of dengue. Dr. Guirakhoo has over 30 years of experience in developing vaccines against infectious diseases. Dr. Guirakhoo holds a BSc in Biology, a MSc in genetics, and a PhD in Virology from the Medical University of Vienna, Austria, and was awarded a National Research Council post-doctoral fellowship at the National Center for Disease Control and Prevention in Fort Collins, CO, from 1990-1992.

Catherine Mullié obtained a PhD in Microbiology and a PharmD at the University of Lille, France, in 1999. After a post-doc year at the Faculté de Medicine in Amiens (Laboratoire d’Immunologie, INSERM-EMI 0351), she was appointed as assistant professor at the Faculté de Pharmacie in Amiens in 2000 and joined the LG-2A (Laboratoire de Glycochimie des Antimicrobiens et des Agroressources, UMR 7378 CNRS) in 2008. She has been a member of the French Society for Microbiology since 2000. Her research is focused on the development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii. She currently heads the French part of a bilateral project funded by France and Algeria (Partenariat Hubert Curien Tassili) on this topic.

development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii

Professor Dr. Andy I.M. Hoepelman (26-03-1955) is Head of the Department of Infectious Diseases in the University Medical Center Utrecht in the Netherlands. Until 2016 he was also the head of the Department of Internal medicine. Since August 1st 1998, he is Professor in Medicine. Dr. Hoepelman received his medical training from the University of Utrecht, receiving his Doctorate in 1978 and his MD degree in 1980. He completed two internships at the University in 1980 and 1985 to earn his board certification as a specialist in Internal Medicine. He received his PhD in 1989. In 1991/1992 he worked at the Rockefeller University, New York (Laboratory Prof. E. Tuomanen) and at the Memorial-Sloan Kettering (Department of Infectious Diseases, Prof.dr. D. Armstrong). In 1993, he was board certified as a specialist in Infectious Diseases. He also heads the training programme in Infectious Disease for internal medicine specialists at the University Hospital Utrecht. He is author/co-author of more than 400 published articles and is a member of several professional associations. His research interests are pathogenesis and treatment of HIV and viral hepatitis. He won a bronze medal in waterpolo at the Montreal Olympics

pathogenesis, treatment of HIV and viral hepatitis

Huseyin Kayadibi was born and raised in Istanbul, Turkey. He received a Degree in Medicine from the GATA School of Medicine (Turkey) in 2000. He is an Associate Professor in Medical Biochemistry at Hitit University School of Medicine, where he is the head of Medical Biochemistry. He worked at Pasarow Mass Spectrometry Laboratory, University of California Los Angeles in 2012 as a visiting scholar. He has been a co-investigator on NIH and other international projects about metabolomic, proteomic and lipidomic analysis. He is the member of EFLM Working Group Test Evaluation and IFCC Working Group Cerebrospinal Fluid Proteins. He has published more than 70 papers in peer reviewed journals. His research interests are non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Refat Sadeq, Prof. and Head of Medical Microbiology and Immunology Department, Faculty of Medicine, Port said University, Egypt. He has been on microbiology field over 40 years. He has started and graduated in Zagazig Faculty of Medicine for M.Sc. and Ph.D. Then started to research articles reaching more than 80 articles, many of which have been published in international scientific journals, and he has reviewed over 150 articles on different journal sites. He is a Featured Author, for books in Medical Microbiology and Immunology for both medical students and nurses. Work from 2008-2011 as Head of Microbiology Department, Faculty of Medicine- Zagazig University. Also work as member of Egyptian scientific committee for graduation of Professor and assistant Professor in Microbiology in Egypt and some Arabic countries. He signed as Board editor of EC Microbiology Journal and Journal of Human Virology and Retrovirology. Since Oct 2014 he pointed as a Head of Microbiology and Immunology department, Faculty of Medicine, Port said University. He is very goal-oriented, assisted in building many units in his department but the favorite one was that of Virology and Molecular biology. He loves how to help junior doctors in his department to solve their scientific problems. His advice to new contributors is to take your time to get to know all the tools and to invest your energy and be sure that success will happened.

Virology and Molecular biology.

Professor Janak Kishore is Chief of Serology and Molecular Virology in the department of Microbiology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, India. He was Associate Editor Indian Journal of Virology, member National Academy Medical Sciences, American societies and Fellow of JICA, Japan. His passion is on healing and minimising human sufferings; on unveiling emerging viral infections and finding aetiologies in viral epidemics and in investigating undiagnosed/missed clinical infections so that appropriate treatment is given and life is saved. Dr. Kishore taught for over 30 yrs with pioneer work on parvovirus B19, developed in-house molecular techniques and published three novel clinical associations besides finding novel oncolytic property of B19. He also worked on cytomegalovirus, enteroviral haemorrhagic conjunctivitis, rubella. Dr Kishore published over 50 papers, served as reviewer for reputed journals, organized conferences, Chaired sessions and frequently invited to speak at international conferences.

Emerging viral infections,Viral epidemics and Clinical Infectious Diseases.

Dr Ashok Kapse is consulting Pediatrician practicing in the city of Surat in the Gujrat state of India, besides owning a private pediatric hospital he is also head of the pediatric department at a prestigious Mahavir super specialty hospital. He has special interest and skill in infectious diseases. Working along with CDC Atlanta he evolved simple clinical approach for diagnosis and management of Dengue illnesses particularly in resource limited situations. Recipient of many oration awards he is a popular and sought after speaker, he has delivered hundreds of lectures on Dengue, Malaria, Typhoid and antibiotic uses across the India. He has published more than 10 articles in reputed national & international journals also has contributed chapters in prestigious books.

Dengue, Malaria, Typhoid and Antibiotics

Professor Dr. Reza Nejat (1963) is Chief of Khatam-ol-Anbia Hospital, Mashhad University of Medical Sciences, 1992-1994, Taibad City, Khorasan Province, Iran. Emergency Dept of Tehranpars General Hospital 1994-2009. Emergency Dept of Iranmehr General Hospital 1997-2000. Chief of Imam Khomeini Firuzkuh Hospital, Shahid Beheshti University of Medical Sciences, 2006-2007, Firuzkuh, Tehran Province, Iran. Directing Manager of Biotourism, Consultant to Deputy of Therapeutics, Shahid Beheshti University of Medical Sciences, 2007 to March, 2008. Member of managerial board of the committee of Health Tourism, Consultant to The Chancellor of Shahid Beheshti University of Medical Sciences in Health Tourism, March 2008-September 2008. Staff of Open Heart Surgery ICU of Day General Hospital, Tehran, Iran, June 2008-September 2009. Staff of ICU of Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, August 2008-March 2011. Assistant Professor, Anesthesiology Dept. at Shahid Beheshti University of Medical Sciences, Tehran, Iran, March 2011 onward. Assistant Professor, Anesthesiology Dept., ICU at Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, March 2011-April 2011. Assistant Professor, Anesthesiology Dept. at 15th Khordad Hospital, OR of plastic and reconstruction surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran, April 2011-April 2012. Assistant Professor, Anesthesiology Dept. at Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, April 2012-January 2013. Critical Care fellowship programme at Sina Hospital, Tehran University of Medical Sciences, January 2013-July 2014. Assistant Professor, Fellowship of Critical Care Medicine (FCCM), ICU, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, July 2014-May 2015. Chief of CCM Dept., Bazarganan Hospital, Feb 2016- till now

Echocardiography, acute heart failure, stress response, sepsis and IVIG.

Daniel Bauer is internationally revered as the Successor to the legendary escape artist Harry Houdini and globally respected as a 12-year warrior and survivor living with HIV/AIDS. Through heart-breaking loss, such as burying his baby brother who passed from AIDS-related complications, to conquering impossible moments of rare survival, he has gracefully triumphed to once again pursing his dreams. He is one the most requested motivational public speakers and entertainers who continues to present highly engaging educational experiences and spectacularly, life-changing theatrical productions to tens of thousands annually (adolescents, healthcare professionals and mainstream communities &audiences at-large) focusing on topics such as living with HIV/AIDS, prevention, reversing HIV/AIDS-related man-made stigma and so much more. He is the current active celebrity voice and face of JustGetTested.com. He continues to work tirelessly to promote equality for all living with and/or affected by the global HIV/AIDS pandemic. His work as both an escape artist and speaker have been featured on: National Television Networks [NBC, CBS, ABC and FOX], International print/radio media (i.e. poz.com/blogs, positivelite.com, NPR Radio, Poz I Am Radio Show),International Theatrical Stages including New York City off-Broadway; and has been highlighted at internationally revered events such as The OMICS Group2013 International HIV/STI Conference, The National Healthy Living Summit, 2012 International AIDS Conference (AIDS Reunion Program, Washington, D.C.), The 2013 University of Minnesota African Student Association Red Spots Gala, and The Texas State-wide HIV/HEI Conference.

HIV

Charbell Miguel Haddad Kury, a Medical Doctor and Professor of Medicine, graduated from the Medical School of the Municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil in 2003. He is expert in Public Health, from the Medicine School of Campos dos Goytacazes, in 2004. He is Pediatrician infectious disease specialist from the Jesus Hospital, Rio de Janeiro in 2007. He is also a Professor of Pediatrics of the Medicine Schools of Campos dos Goytacazes and the Federal University of Rio de Janeiro, Brazil. He has a Master’s degree in Applied Microbiology and Parasitology from the Fluminense Federal University, in 2013. He is a Pediatrician and Neonatologist of the St. John the Baptist Hospital, Municipality of Macaé, State of Rio de Janeiro, Brazil, since 2005 and Coordinator of Immunization and Health Surveillance of the Municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil, since 2009. He did research on immunization programs, once the municipality of Campos dos Goytacazes implemented the largest immunization program.

Public Health,HIV/AIDS

Hiroshi Ohrui has received Ph.D. degree (1971) from The University of Tokyo. He joined RIKEN (1966), moved to Tohoku University (1881) and then to Yokohama University of Pharmacy (2006). His interest covers Organic Synthesis, Chemical Biology, and Chiral Discrimination.

HIV

Dr. NWAKO Okechukwu Francis had his B.Sc in Applied Microbiology(upper credit ) in 2001 and proceeded to Medical School where he graduated in 2009. In 2012, he obtained his M.Sc( Medical Microbiology) and has completed his Ph.D course work in Medical Microbiology with major in Mycology. He hope to complete his research work by 2016. He obtained his Primary in Internal Medicine in 2010 and became a specialist in Internal Medicine in 2015 from the West Africa College of Physicians. He has published several original articles in international journals and has attended several conferences both locally and internationally including the famous HIV/AIDS 2013 organized by OMICS conferences. He has reviewed many articles for British Journal of Medicine and Medical Research and Journal of AIDS.

HIV

Daniel Bauer is internationally revered as the Successor to the legendary escape artist Harry Houdini and globally respected as a 12-year warrior and survivor living with HIV/AIDS. Through heart-breaking loss, such as burying his baby brother who passed from AIDS-related complications, to conquering impossible moments of rare survival, he has gracefully triumphed to once again pursing his dreams. He is one the most requested motivational public speakers and entertainers who continues to present highly engaging educational experiences and spectacularly, life-changing theatrical productions to tens of thousands annually (adolescents, healthcare professionals and mainstream communities &audiences at-large) focusing on topics such as living with HIV/AIDS, prevention, reversing HIV/AIDS-related man-made stigma and so much more. He is the current active celebrity voice and face of JustGetTested.com. He continues to work tirelessly to promote equality for all living with and/or affected by the global HIV/AIDS pandemic. His work as both an escape artist and speaker have been featured on: National Television Networks [NBC, CBS, ABC and FOX], International print/radio media (i.e. poz.com/blogs, positivelite.com, NPR Radio, Poz I Am Radio Show),International Theatrical Stages including New York City off-Broadway; and has been highlighted at internationally revered events such as The OMICS Group2013 International HIV/STI Conference, The National Healthy Living Summit, 2012 International AIDS Conference (AIDS Reunion Program, Washington, D.C.), The 2013 University of Minnesota African Student Association Red Spots Gala, and The Texas State-wide HIV/HEI Conference.

HIV

Baran Halina is presently Head of the Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Treatment Mauer, Lower Austria, from 2005-2011 she was the head of Head of the Neurochemical Laboratory Karl Landsteiner Institute Mauer and Head of Neurophysiology, Veterinary Medical University Vienna. In the year 1998-2005, she was Assoc. Prof. at Institute of Pharmacology and Toxicology, Veterinary Medical University Vienna.

HIV

Michelle Moorhouse graduated from Wits University in South Africa, and qualified as a GP anaesthetist. Then, like many of her peers, switched her professional track to the management of HIV. Michelle co-founded Triple M Research, placing Port Elizabeth firmly on the map as one of the first HIV clinical trial centers in the Eastern Cape. Michelle went on to found the HIV journal club in PE, which later became the local chapter of the Southern African HIV Clinicians Society. In 2003 Michelle was awarded an Honorary Clinical Fellowship at the Royal Free Hospital in London. She has also worked in the pharmaceutical industry, holding senior advisory posts at Abbott and Boehringer, she led the UK launch of Tipranavir in 2005, and was medical director at Novartis Vaccines and acting head of HIV therapeutics at GSK. Whilst working in the UK, Michelle earned the respect of many leading internationally renowned HIV clinicians. Michelle returned to South Africa in 2007, where she re-established her general/HIV practice - much to the excitement of a number of patients who started ARV treatment under her management many years earlier! Michelle went on to found a research centre that focused on HIV clinical trials, and also provided principle investigator services to local CROs. Consulting at a local clinic in Motherwelltownship for IYDSA, an Eastern Cape based NPO, signaled a change in Michelle’s career. This branch of public health brought her closer to the other realities of the HIV/AIDS epidemic, providing an opportunity to play a greater part in tackling the disease that she has dedicated her career to so passionately. She later joined full-time, initially as Clinical Advisor, and then Technical Lead Research and Training, proudly contributing to the NGO's rapid growth, rebranding to Beyond Zero, and becoming one of the leading HIV/AIDS focused NPOs in the Eastern Cape. In 2012, Michelle was elected to the inaugural Board of Directors of the Southern African HIV Clinicians Society, devoting much of her time to organisational development, supporting new treatment guidelines, conceptualising a new corporate membership programme, and of course, a little bit of activism against HIV/AIDS quackery(!), and supporting the biennial Clinicians Society Conference She is also member of the Editorial Boards of HIV Nursing Matters magazine, and the MRC AfroAIDSinfo portal, as well as a member of MedDigital Expert Panel and HIV Physicians Panel. In September 2014, Michelle took up an exciting position as Senior Clinician at Wits Reproductive Health and HIV Institute (RHI), and relocated to Johannesburg. In this role, she is actively engaged in clinical work, research and teaching, as well as sitting on National HIV guideline committees, advising the National Department of Health, training the master trainers of the 9 provinces on new guidelines, to mention a few of her responsibilities. Michelle has recently been appointed to the national Third Line ART Committee, which reviews patients failing their second line regimen (or beyond) and advises regarding their further management for the National Department of Health. Michelle is particularly interested in ARV resistance, helping HIV affected couples have healthy babies, and sharing her HIV knowledge through talks, workshops and training.

HIV

Bernardino Geraldo Alves Souto was graduated in medicine at Federal University of Juiz de Fora, Minas Gerais, Brazil, in 1987. Received his master's degree in 2002 and Ph.D. in 2006, in Infectious Diseases and Tropical Medicine, at Federal University of Minas Gerais, Brazil. Specialist in Intensive Care Medicine, Clinical Medicine/Internal Medicine and Epidemiology. Professor of the Department of Medicine of the Federal University of São Carlos, São Paulo, Brazil. Practices general integral medicine and is attending physician at Specialized Care Service in STD/HIV/Aids of São Carlos, São Paulo, Brazil. As researcher, mainly investigates the epidemiology of HIV infection, and the psychological and social issues related to people living with this virus.

HIV/AIDS

Charbell Miguel Haddad Kury, a Medical Doctor and Professor of Medicine, graduated from the Medical School of the Municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil in 2003. He is expert in Public Health, from the Medicine School of Campos dos Goytacazes, in 2004. He is Pediatrician infectious disease specialist from the Jesus Hospital, Rio de Janeiro in 2007. He is also a Professor of Pediatrics of the Medicine Schools of Campos dos Goytacazes and the Federal University of Rio de Janeiro, Brazil. He has a Master degree in applied microbiology and parasitology from the Fluminense Federal University, in 2013. He is a Pediatrician and Neonatologist of the St. John the Baptist hospital, municipality of Macaé, State of Rio de Janeiro, Brazil, since 2005 and Coordinator of Immunization and Health surveillance of the municipality of Campos dos Goytacazes, State of Rio de Janeiro, Brazil, since 2009. He did research on immunization programs, once the municipality of Campos dos Goytacazes implemented the largest immunization program in early 2009.

HIV

D K Agarwal has 24 years of experience in the field of Nephrology including specialization in renal transplant, hemodialysis, CAPD and all kidney problems and diseases along with critical kidney patients with emergency management. He is well experienced in handling kidney patients with diabetes and hypertension and other diseases. He is also well experienced in renal transplantation in HIV patients. He worked as Senior Consultant, Nephrologist in various institutions of National and International repute like Nizam’s Institute of Medical Sciences, Hyderabad, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow etc. He isexperienced at division of Nephrology, Department of Medicine, University of Missouri, School of Medicine, Columbia, USA. At present he is working as Senior Consultant in Nephrology and renal transplant, Indraprastha Apollo Hospitals, New Delhi, India.

HIV/AIDS

Nwako Okechukwu Francis is a registrar in medicine department of Federal medical centre Owerri and a medical microbiologist with about 3 years teaching experience. He obtained B.Sc in microbiology in 2001, MBBS in 2009, primary fellowship in 2010 and M.Sc in medical microbiology in 2012. He has done some published work Nigeria. His on the job experience in the care and management of HIV positive clients in a resource poor setting ignited his interest in HIV medicine. His keen interest is in opportunistic infections in HIV/AIDS. He has applied to study Infection and Immunity in Ph.D in Nigeria. He is a member of NMA, associate fellow of WACP, associate fellow of NPMC, member NSM and NARD.

HIV

Huynh has received Ph.D. in Bio-Organic chemistry from the University of Tokyo, Japan, in 1979. He was chemist at Nippon Kayaku Chemical Co. Japan and postdoc with School of Pharmacy, Purdue University. He worked with Stanford Research Institute International, in Bio-Organic Chemistry Department, and Applied Biosystems Inc., in R&D Department. Huynh was senior manager in anti-HIV research at Triplex Pharmaceuticals Inc., and molecular diagnostic research at Gen-Probe Inc. From 2009, he worked as CSO of Genomeplex Research Institute, Inc. for manufacturing of Real Time PCR for HIV-1 virus. He has more than 200 presentations, publications and product developments with companies.

Andrew D. Badley, M.D., was born in Sydney, Nova Scotia, Canada. He earned his B.S. degree in 1985 and M.D. degree in 1990, both from Dalhousie University in Halifax, Nova Scotia. After completing residency training in internal medicine at Mayo Clinic in Rochester, Minn., in 1994, Dr. Badley completed further training at Mayo Clinic as a clinician investigator trainee in the Division of Infectious Diseases in 1997. During his training, Dr. Badley received the Dr. J. Geraci Award for Excellence in Infectious Diseases from Mayo Clinic in June 1997, as well as the Young Investigator Award from the Interscience Conference on Antimicrobial Agents and Chemotherapy and American Society for Microbiology (ICAAC/ASM) in September 1997. Dr. Badley joined the staff of Ottawa Hospital in Ottawa, Ontario, Canada, in 1997 as an assistant professor in the Division of Infectious Diseases and in 2002 was promoted to an associate professor. In 2002, Dr. Badley returned to Mayo Clinic in Rochester as a consultant in the Division of Infectious Diseases and brought with him his successful research program. At Mayo Clinic, Dr. Badley is currently a professor of medicine and consultant in the Division of Infectious Diseases; associate director of the Research Resources component of the Center for Translational Science Activities; and theme leader for infectious disease research on the Research Development Council, an internal Mayo committee.

virus-host interactions, in particular how viral proteins modify the host immune response and/or cell survival.

erthold Kepplinger was medical director of the neuro-rehabilitation Wall Amstetten and the Neuro Rehabilitation and Pain Wall Amstetten and Head of acute Logie and Stroke Unit. In the past 10 years, he worked as medical director of the State Hospital Wall Amstetten.

Baran Halina is presently Head of the Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Treatment Mauer, Lower Austria, From 2005 - 2011 she was the head of Head of the Neurochemical Laboratory Karl Landsteiner Institute Mauer and Head of Neurophysiology, Veterinary Medical University Vienna.

Francois Villinger, DVM, PhD, Chief of the Yerkes Division of Pathology, graduated from the University of Zurich, Switzerland. The primary research interests of Dr. Villinger and his lab team are modeling human infectious diseases in relevant nonhuman primate models, particularly for those diseases without other models and those that do not reproduce human pathogenesis. These diseases include HIV/AIDS as well as infection models of XMRV, dengue fever and listeria. As Chief of the Division of Pathology, Dr. Villinger oversees the administrative functions of the division. This entails oversight of the administrative staff, approving grant submissions by division faculty and trainees, ensuring appropriate allocation of division resources and mentoring junior faculty. Dr. Villinger is involved in reporting division research activities to the National Center for Research Resources (NCRR) and preparing progress and plan descriptions of division research activities for the Yerkes Research Center’s P51 base grant renewal. Dr. Villinger also serves as the liaison between division staff and the Yerkes administration, and advises the director on issues related to the scientific mission of the Center. In addition, the Villinger lab runs a NCRR-funded resource that provides nonhuman primate specific immunomodulatory reagents, such as recombinant cytokines and soluble forms of immune-receptors, to investigators on a national and international level. The Yerkes research center provides 60 samples annually.

Immunology of infectious diseases, AIDS and resource for nonhuman primate immune reagents.

Stela Halichidis is a director in the Department of Medical Faculty at Ovidius University, Romania. She was head of HIV department, Constanta, Romania. She has published various papers related to HIV, and is member in many national and international medical associations (ESCMID, ESC, Romanian Infectious Diseases Society, Balcanic Medical Society, Romanian Parasitology Society, International AIDS Society, and Balkan Environmental Association).

Daniel Bauer is internationally revered as theSuccessor to the legendary escape artist Harry Houdini and globally respected as a 12-year warrior and survivor living with HIV/AIDS.Through heart-breaking loss, such as burying his baby brother who passed from AIDS-related complications, to conquering impossible moments of rare survival, Daniel Bauer has gracefully triumphed to once again pursing his dreams. Daniel Bauer is one the most requested motivational public speakers and entertainers who continues to present highly engagingeducational experiences and spectacularly, life-changing theatrical productions to tens of thousands annually(adolescents, healthcare professionals and mainstream communities &audiences at-large)focusing on topics such as living with HIV/AIDS, prevention, reversing HIV/AIDS-related man-made stigma and so much more. Daniel Bauer is the current active celebrity voice and face of JustGetTested.com. He continues to work tirelesslyto promote equality for all living with and/or affected by the global HIV/AIDS pandemic. His work as both an escape artist and speaker have been featured on: National Television Networks [NBC, CBS, ABC and FOX], International print/radio media (i.e. poz.com/blogs, positivelite.com, NPR Radio, Poz I Am Radio Show),International Theatrical Stages including New York City’s off-Broadway; and has been highlighted at internationally revered events such as The OMICS Group2013 International HIV/STI Conference, The National Healthy Living Summit, 2012 International AIDS Conference (AIDS Reunion Program, Washington, D.C.), The 2013 University of Minnesota African Student Association Red Spots Gala, and The Texas State-wide HIV/HEI Conference. And if that is not enough of an iconic ship of accomplishment, Bauer has also held prime consulting and contractual professional positions in the fields of government, education, special event planning, fund raising and youth development programming to promote healthy-living and equality for all walks of life while continuing to create waves, inspire hope and promote positive change among our communities to unite global synergistic efforts in the fight against HIV/AIDS.

Design and analysis of clinical trials for vaccines against infectious diseases, Statistical methods in immunological assay validation and evaluation, Statistical methods in equivalence testing, Immune correlates of protection and Meta-analysis.

Dr. Aboul-Ata Elnady ABOUL-ATA, Professor Dr. of Plant virology, who was born on Mar.22nd 1948 in Sharkia, Egypt, is the president of ArSV (Arab Society for Virology) in 2013. He was formerly Department Head of Plant Virus and Phytoplasma Research, Plant Pathology Research Institute at Agricultural Research Center, Giza, Egypt for 3 years (2003-2006), and Head of Molecular laboratory at Plant Virus and Phytoplasma Res. from Sep. 2005 up to now. Dr. Aboul-Ata is the author of more than 40 scientific papers in different approaches like gene silencing, sequencing of viral genes. He lead an Egyptian research group (human virologists and molecular biologists) for a Swedish-funded project on Plant-based vaccine against HSV-2 in collaboration with Gothenburg University, Sweden throughout 2007-2010. He also lead a MERC project on detection of cereal viruses for prevention through quarantine system in Middle East countries (Egypt, Jordan, Israel and Palestine) throughout 2008-2011. He is in charge of nanoscience introduction to the domain of plant virology at Plant Pathology Research Institute. He is chosen for general-, scientific- and organizing-committee member for the First and 2nd Conference of Virology, which was organized by ESV at 2004 and 2008, Cairo, Egypt. He has also been chosen to be International Advisory-committee member for the 2nd Green revolution in India that is organized from 2-5 July, 2009. He is an evaluation-committee member for promotion to higher scientific position i.e. Assoc. Professorship and Professorship at Institute of Plant Pathology, ARC, Egypt 2008 up to now.

Dr. Nafees Ahmad received his B. S.(Hons) in Chemistry and M. S. in Biochemistry from one of the prestigious central universities in India, The Aligarh Muslim University. He then joined another renowned research institute, The Central Drug Research Institute, Lucknow, India, from where he earned his Ph.D. in 1983. Dr. Ahmad did his Postdoctoral Fellowship at the National Institutes of Health (NIH), Bethesda, Maryland, USA from 1985-1990 in the Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases. His research primarily focused on the regulation of HIV-1 gene expression and replication, especially the role of HIV-1 regulatory and accessory proteins in HIV-1 replication and biology. In 1990, a group of scientists from the NIH, including Dr. Ahmad moved to J.N. Gamble Institute of Medical Research, Cincinnati, Ohio to start a new program on Molecular Virology, including his own independent research program on molecular mechanisms of HIV-1 mother-to-infant transmission. In 1994, Dr. Ahmad joined the University of Arizona College of Medicine’s Department of Microbiology and Immunology (now Immunobiology). His research involves understanding the molecular mechanisms of differential HIV infection in infants and adults and vertical transmission and pathogenesis. In addition, he directs the Immunity and Infection block of the medical curriculum of the College of Medicine.

Dr. Ramendra K. Singh, an Associate Professor of Chemistry at the University of Allahabad, India, is Director of the Nucleic Acids Chemistry and Antiviral Research laboratory and is member of several national committees. He has several awards/fellowships, like ISCA Young Scientists Award, INSA Visiting Fellowship, UNESCO Fellowship, XVI IUBMB Fellowship, Jawaharlal Nehru Visiting Fellowship, Post-Doc Fellowship, Govt of Japan, INSA International Exchange Fellowship and Fulbright-Nehru Senior Research Fellowship to his credit. His research interest lies in computer-aided designing and development of antiviral molecules against HIV, HPV and JEV and developing fluorescent oligonucleotides for use in the field of molecular biology and diagnostics. He has about a dozen anti-HIV and half-a-dozen anti-JEV compounds under patent processing. Dr. Singh is on editorial board of several international journals and referee to more than a dozen journals.

Heather initially completed her BS in Biology at the University of North Carolina, Chapel Hill, moving on to study for an MD/PhD in Molecular and Cell Biology at Tulane University, New Orleans, qualifying in 1999. She currently is a Senior Scientist at Seattle Biomed and a Senior Lecturer at University of Cape Town. She also holds an affiliate Associate Professorship at University of Washington’s Department of Global Health.

prevention of HIV acquisition in children and adolescents and immunology thereof.